Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Assess the Long-term Safety and Efficacy of Pravafenix Cap. in Korean Patients With Dyslipidemia: a Multicenter, Prospective, Observational Study

NCT03214211 is registered in ClinicalTrials.gov with Yooyoung Pharmaceutical Co., Ltd. as lead sponsor.

NCT NCT03214211
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03214211 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Assess the Long-term Safety and Efficacy of Pravafenix Cap. in Korean Patients With Dyslipidemia: a Multicenter, Prospective, Observational Study
Lead sponsor
Yooyoung Pharmaceutical Co., Ltd.
Phase
Observational
Overall status
Unknown status
Start date
August 30, 2017
Completion date
June 30, 2022
Enrollment
3,088 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

dyslipidemias